|
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
|
2
|
Zenith Epigenetics
|
May 16, 2018 11:35AM
|
|
FDA approves Migalastat (Galafold) from Amicus for Fabry disease
|
3
|
Resverlogix Corp.
|
Aug 11, 2018 01:25PM
|
|
HDL from an Alzheimer's disease perspective
|
5
|
Resverlogix Corp.
|
Jun 27, 2019 08:41AM
|
|
Prostate Cancer Foundation Retreat 2019 - Poster
|
4
|
Zenith Epigenetics
|
Oct 31, 2019 02:58PM
|
|
Resverlogix Announces 3-Month Loan Extension
|
1
|
Resverlogix Corp.
|
May 02, 2019 09:46PM
|
|
RVX AGM Q&A, post AGM-huddle, impressions
|
5
|
Resverlogix Corp.
|
Sep 18, 2018 08:29PM
|
|
Zenith Announces Annual and Special Meeting of Shareholders
|
1
|
Zenith Epigenetics
|
Aug 22, 2019 07:16PM
|
|
"Getting cancer drugs into the brain" article in Nature Outlooks mentions BiOasis
|
4
|
BIOASIS TECHNOLOGIES INC
|
Sep 27, 2018 09:54AM
|
|
10-41: Re: Haven't written off a potential role for Apabetalone to play yet.
|
1
|
Resverlogix Corp.
|
Apr 02, 2020 06:16PM
|
|
10/28/16 Financial Statement and MD&A on SEDAR
|
2
|
BIOASIS TECHNOLOGIES INC
|
Oct 29, 2016 11:04PM
|
|
11 months into BETonMACE
|
6
|
Resverlogix Corp.
|
Oct 10, 2016 12:00PM
|
|
2 events this week
|
3
|
Resverlogix Corp.
|
Mar 05, 2017 06:07PM
|
|
2 year anniversary of the initial ASSURE news release
|
1
|
Resverlogix Corp.
|
Jun 29, 2015 01:04PM
|
|
2016 Outlook Video
|
7
|
Resverlogix Corp.
|
Feb 17, 2016 04:53PM
|
|
2017 Review Paper on RVX-208
|
1
|
Resverlogix Corp.
|
May 10, 2017 03:14PM
|
|
2019 Annual and Special Meeting of Shareholders and Webcast of Corporate Update
|
6
|
Zenith Epigenetics
|
Oct 30, 2019 11:24AM
|
|
2019 Annual and Special Meeting of Shareholders and Webcast of Corporate Update
|
7
|
Resverlogix Corp.
|
Oct 29, 2019 12:06PM
|
|
2019 Potential Events
|
4
|
Resverlogix Corp.
|
Nov 27, 2018 12:02PM
|
|
3 ASN Kidney Conference Presentations Nov 8-9
|
4
|
Resverlogix Corp.
|
Nov 07, 2019 07:26PM
|
|
3 Presentations March 26-March 30, 2020
|
11
|
Resverlogix Corp.
|
Feb 20, 2020 02:05PM
|
